We are live on ! Find out more
DALS

DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS

Delisted

DALS was delisted on the 28th of July, 2023.

Back to rankings

45 hedge funds and large institutions have $140M invested in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 4

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

2% more funds holding

Funds holding: 44 → 45 (+1)

7% less capital invested

Capital invested by funds: $150M → $140M (-$10.8M)

Holders
45
Holders Change
+1
Holders Change %
+2.27%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
10
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AA
AQR Arbitrage
Connecticut
+$2.5M
2
CF
Cantor Fitzgerald
New York
+$1.6M
3
CSS
Cubist Systematic Strategies
Connecticut
+$1.37M
4
SCM
Saba Capital Management
New York
+$1.34M
5
Citadel Advisors
Citadel Advisors
Florida
+$1.22M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$4.86M
2
ACA
Arena Capital Advisors
California
-$2.5M
3
PVI
Pura Vida Investments
New York
-$1.6M
4
SCM
Soleus Capital Management
Connecticut
-$486K
5
UFM
Ursa Fund Management
California
-$243K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$15.5M – – –
BlackRock
2
BlackRock
New York
$14.5M – – –
RCM
3
RA Capital Management
Massachusetts
$14.5M – – –
SCM
4
Saba Capital Management
New York
$12.2M +$1.34M +138,000 +12%
Marshall Wace
5
Marshall Wace
United Kingdom
$8.69M – – –
Millennium Management
6
Millennium Management
New York
$8.5M – – –
SC
7
Sculptor Capital
New York
$7.44M +$37.9K +3,900 +0.5%
MCM
8
Moore Capital Management
New York
$7.27M – – –
Citadel Advisors
9
Citadel Advisors
Florida
$6.99M +$1.22M +125,000 +21%
Alyeska Investment Group
10
Alyeska Investment Group
Illinois
$4.84M – – –
RIA
11
RP Investment Advisors
Ontario, Canada
$4.03M +$65.5K +6,735 +2%
LA
12
Linden Advisors
New York
$3.69M – – –
AA
13
AQR Arbitrage
Connecticut
$2.49M +$2.5M +257,328 New
Victory Capital Management
14
Victory Capital Management
Texas
$2.29M – – –
GCM
15
Ghisallo Capital Management
Massachusetts
$2.18M – – –
SCM
16
Shaolin Capital Management
Florida
$2.18M +$459K +47,223 +27%
NIP
17
Nicholas Investment Partners
California
$1.94M – – –
WCMNY
18
Westchester Capital Management (New York)
New York
$1.61M – – –
RCM
19
Radcliffe Capital Management
Pennsylvania
$1.6M +$186K +19,082 +13%
CF
20
Cantor Fitzgerald
New York
$1.6M +$1.6M +164,834 New
WRBC
21
W.R. Berkley Corp
Connecticut
$1.52M – – –
JP Morgan Chase
22
JP Morgan Chase
New York
$1.45M – – –
CL
23
CSS LLC
Illinois
$1.45M +$336K +34,490 +30%
CSS
24
Cubist Systematic Strategies
Connecticut
$1.36M +$1.37M +140,918 New
Verition Fund Management
25
Verition Fund Management
Connecticut
$1.24M +$332K +34,100 +36%
1
2

DALS Hedge Fund Activity: Q2 2022 in Review

45 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) for Q2 2022, worth a combined $140M — down 7.2% from $150M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new DALS positions and 5 closed out — a net gain of 1 holder — while 10 added to existing stakes and 4 trimmed.

The largest buyer was AQR Arbitrage, opening a new position worth an estimated $2.5M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $4.86M sold.

  • 45 institutional investors held DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) as of Q2 2022, up from 44 in Q1 2022.
  • Funds reported $140M of DA32 Life Science Tech Acquisition Corp. Class A Common Stock stock for Q2 2022, down 7.2% quarter-over-quarter.
  • 6 funds opened new DA32 Life Science Tech Acquisition Corp. Class A Common Stock positions in Q2 2022 and 5 closed out, a net change of +1 holder.
  • The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock buyer in Q2 2022 was AQR Arbitrage, an estimated $2.5M added.
  • The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock seller in Q2 2022 was Perceptive Advisors, an estimated $4.86M sold.

Based on aggregated 13F filings for Q2 2022.